Shionogi launches ADHD drug Intuniv in Japan

Shionogi & Co. Ltd. (Tokyo:4507) launched Intuniv guanfacine in Japan to treat pediatric ADHD. The Japanese National Health Insurance (NHI) list price of the once-daily adrenergic receptor alpha 2a (A...